Skip to main content
Erschienen in:

12.09.2023 | Short Communication

The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake

verfasst von: Gaia Ninatti, Cristiano Pini, Fabrizia Gelardi, Samuele Ghezzo, Paola Mapelli, Maria Picchio, Lidija Antunovic, Alberto Briganti, Francesco Montorsi, Claudio Landoni, Martina Sollini, Arturo Chiti

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Aim

Unspecific bone uptake is one of the main limitations of PET imaging with some PSMA-targeting radiopharmaceuticals, especially with [18F]PSMA-1007. We explored the potential association between osteoporosis and the occurrence of unspecific [18F]PSMA-1007 bone uptake investigating markers which might correlate with bone mineral density.

Materials and methods

We retrospectively analyzed treatment-naïve patients with a confirmed diagnosis of prostate adenocarcinoma who underwent staging [18F]PSMA-1007 positron emission tomography (PET). Qualitative image analysis was performed independently by three experienced nuclear medicine physicians. Patients were divided in two groups according to the presence/absence of unspecific bone uptake. Clinical information, blood count parameters (assessed within 3 months to the PET scan), body mass index (BMI), and bone density as estimated by computed tomography were collected. The Kruskal–Wallis and t-test were used to compare parameters.

Results

We analyzed 77 patients: 29 of them (38%) had unspecific bone uptake at [18F]PSMA-1007 PET, most commonly in the pelvic bones (69%) and ribs (62%). We did not find any significant difference in clinical parameters in the two groups. In patients with unspecific bone uptake, white blood cell, and neutrophil counts were significantly higher; in the same group, we observed lower values of BMI and bone density, although not statistically different.

Conclusions

We observed unspecific bone uptake on [18F]PSMA-1007 PET in more than 1/3 of patients. In this exploratory analysis, we found a significant correlation between blood count parameters and unspecific [18F]PSMA-1007 bone uptake. We may speculate that [18F]PSMA-1007 unspecific bone uptake could be associated with osteoporosis. This hypothesis needs to be further investigated in larger populations and exploring more specific markers of osteoporosis.
Literatur
1.
Zurück zum Zitat Alberts IL, Seide SE, Mingels C, Bohn KP, Shi K, Zacho HD, et al. Comparing the diagnostic performance of radiotracers in recurrent prostate cancer: a systematic review and network meta-analysis. Eur J Nucl Med Mol Imaging; 2021;48:2978–89. Alberts IL, Seide SE, Mingels C, Bohn KP, Shi K, Zacho HD, et al. Comparing the diagnostic performance of radiotracers in recurrent prostate cancer: a systematic review and network meta-analysis. Eur J Nucl Med Mol Imaging; 2021;48:2978–89.
2.
Zurück zum Zitat Rauscher I, Krönke M, König M, Gafita A, Maurer T, Horn T, et al. Matched-pair comparison of 68Ga-PSMA-11 PET/CT and 18F-PSMA-1007 PET/CT: frequency of pitfalls and detection efficacy in biochemical recurrence after radical prostatectomy. J Nucl Med. 2020;61:51. Rauscher I, Krönke M, König M, Gafita A, Maurer T, Horn T, et al. Matched-pair comparison of 68Ga-PSMA-11 PET/CT and 18F-PSMA-1007 PET/CT: frequency of pitfalls and detection efficacy in biochemical recurrence after radical prostatectomy. J Nucl Med. 2020;61:51.
3.
Zurück zum Zitat Arnfield EG, Thomas PA, Roberts MJ, Pelecanos AM, Ramsay SC, Lin CY, et al. Clinical insignificance of [18F]PSMA-1007 avid non-specific bone lesions: a retrospective evaluation. Eur J Nucl Med Mol Imaging. 2021;48:4495–507. Arnfield EG, Thomas PA, Roberts MJ, Pelecanos AM, Ramsay SC, Lin CY, et al. Clinical insignificance of [18F]PSMA-1007 avid non-specific bone lesions: a retrospective evaluation. Eur J Nucl Med Mol Imaging. 2021;48:4495–507.
4.
Zurück zum Zitat Pattison DA, Debowski M, Gulhane B, Arnfield EG, Pelecanos AM, Garcia PL, et al. Prospective intra-individual blinded comparison of [18F]PSMA-1007 and [68 Ga]Ga-PSMA-11 PET/CT imaging in patients with confirmed prostate cancer. Eur J Nucl Med Mol Imaging. 2022;49:763–776. Pattison DA, Debowski M, Gulhane B, Arnfield EG, Pelecanos AM, Garcia PL, et al. Prospective intra-individual blinded comparison of [18F]PSMA-1007 and [68 Ga]Ga-PSMA-11 PET/CT imaging in patients with confirmed prostate cancer. Eur J Nucl Med Mol Imaging. 2022;49:763–776.
5.
Zurück zum Zitat Seifert R, Telli T, Opitz M, Barbato F, Berliner C, Nader M, et al. Unspecific PSMA-1007 bone uptake evaluated through PSMA-11 PET, bone scan and MRI triple validation in patients with biochemical recurrence of prostate cancer. J Nucl Med. 2023;64(5):738–743. Seifert R, Telli T, Opitz M, Barbato F, Berliner C, Nader M, et al. Unspecific PSMA-1007 bone uptake evaluated through PSMA-11 PET, bone scan and MRI triple validation in patients with biochemical recurrence of prostate cancer. J Nucl Med. 2023;64(5):738–743.
6.
Zurück zum Zitat Hoberück S, Löck S, Borkowetz A, Sommer U, Winzer R, Zöphel K, et al. Intraindividual comparison of [68 Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysis. EJNMMI Res. 2021;11(1):109. Hoberück S, Löck S, Borkowetz A, Sommer U, Winzer R, Zöphel K, et al. Intraindividual comparison of [68 Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysis. EJNMMI Res. 2021;11(1):109.
7.
Zurück zum Zitat Phelps TE, Harmon SA, Mena E, Lindenberg L, Shih JH, Citrin DE, et al. Predicting outcomes of indeterminate bone lesions on 18 F-DCFPyL PSMA PET/CT scans in the setting of high-risk primary or recurrent prostate cancer. J Nucl Med. 2023;64(3):395–401. Phelps TE, Harmon SA, Mena E, Lindenberg L, Shih JH, Citrin DE, et al. Predicting outcomes of indeterminate bone lesions on 18 F-DCFPyL PSMA PET/CT scans in the setting of high-risk primary or recurrent prostate cancer. J Nucl Med. 2023;64(3):395–401.
8.
Zurück zum Zitat Hammes J, Hohberg M, Täger P, Wild M, Zlatopolskiy B, Krapf P, et al. Uptake in non-affected bone tissue does not differ between [18F]-DCFPyL and [68Ga]-HBED-CC PSMA PET/CT. PLoS One. Public Library of Science; 2018;13:e0209613. Hammes J, Hohberg M, Täger P, Wild M, Zlatopolskiy B, Krapf P, et al. Uptake in non-affected bone tissue does not differ between [18F]-DCFPyL and [68Ga]-HBED-CC PSMA PET/CT. PLoS One. Public Library of Science; 2018;13:e0209613.
9.
Zurück zum Zitat Grünig H, Maurer A, Thali Y, Kovacs Z, Strobel K, Burger IA, et al. Focal unspecific bone uptake on [18F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging. Eur J Nucl Med Mol Imaging. Springer; 2021;48:4483. Grünig H, Maurer A, Thali Y, Kovacs Z, Strobel K, Burger IA, et al. Focal unspecific bone uptake on [18F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging. Eur J Nucl Med Mol Imaging. Springer; 2021;48:4483.
10.
Zurück zum Zitat Ioppolo JA, Nezich RA, Richardson KL, Morandeau L, Leedman PJ, Price RI. Direct in vivo comparison of [18F]PSMA-1007 with [68Ga]Ga-PSMA-11 and [18F]AlF-PSMA-11 in mice bearing PSMA-expressing xenografts. Appl Radiat Isot. Pergamon; 2020;161:109164. Ioppolo JA, Nezich RA, Richardson KL, Morandeau L, Leedman PJ, Price RI. Direct in vivo comparison of [18F]PSMA-1007 with [68Ga]Ga-PSMA-11 and [18F]AlF-PSMA-11 in mice bearing PSMA-expressing xenografts. Appl Radiat Isot. Pergamon; 2020;161:109164.
11.
Zurück zum Zitat Piron S, Verhoeven J, Descamps B, Kersemans K, De Man K, Van Laeken N, et al. Intra-individual dynamic comparison of 18F-PSMA-11 and 68Ga-PSMA-11 in LNCaP xenograft bearing mice. Sci Rep. 2020;10(1):21068. Piron S, Verhoeven J, Descamps B, Kersemans K, De Man K, Van Laeken N, et al. Intra-individual dynamic comparison of 18F-PSMA-11 and 68Ga-PSMA-11 in LNCaP xenograft bearing mice. Sci Rep. 2020;10(1):21068.
12.
Zurück zum Zitat Silver DA, Pellicer I, Fair WR, Heston WDW, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res. 1997;3(1):1–5. Silver DA, Pellicer I, Fair WR, Heston WDW, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res. 1997;3(1):1–5.
13.
Zurück zum Zitat Maisto C, Aurilio M, Morisco A, De Marino R, Buonanno Recchimuzzo MJ, Carideo L, et al. Analysis of pros and cons in using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007: production, costs, and PET/CT applications in patients with prostate cancer. Molecules. 2022;27(12):3862.CrossRefPubMedPubMedCentral Maisto C, Aurilio M, Morisco A, De Marino R, Buonanno Recchimuzzo MJ, Carideo L, et al. Analysis of pros and cons in using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007: production, costs, and PET/CT applications in patients with prostate cancer. Molecules. 2022;27(12):3862.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Shigematsu Y, Hirai T, Kawanaka K, Shiraishi S, Yoshida M, Kitajima M, et al. Distinguishing Imaging features between spinal hyperplastic hematopoietic bone marrow and bone metastasis. Am J Neuroradiol. 2014;35:2013–20. Shigematsu Y, Hirai T, Kawanaka K, Shiraishi S, Yoshida M, Kitajima M, et al. Distinguishing Imaging features between spinal hyperplastic hematopoietic bone marrow and bone metastasis. Am J Neuroradiol. 2014;35:2013–20.
16.
Zurück zum Zitat Appelman-Dijkstra NM, Papapoulos SE. Paget’s disease of bone. Best Pract Res Clin Endocrinol Metab. Baillière Tindall; 2018;32:657–68. Appelman-Dijkstra NM, Papapoulos SE. Paget’s disease of bone. Best Pract Res Clin Endocrinol Metab. Baillière Tindall; 2018;32:657–68.
17.
Zurück zum Zitat Shellock FG, Morris E, Deutsch AL, Mink JH, Kerr R, Boden SD. Hematopoietic bone marrow hyperplasia: high prevalence on MR images of the knee in asymptomatic marathon runners. Am J Roentgenol. American Public Health Association; 1992;158:335–8. Shellock FG, Morris E, Deutsch AL, Mink JH, Kerr R, Boden SD. Hematopoietic bone marrow hyperplasia: high prevalence on MR images of the knee in asymptomatic marathon runners. Am J Roentgenol. American Public Health Association; 1992;158:335–8.
18.
Zurück zum Zitat Salari N, Darvishi N, Bartina Y, Larti M, Kiaei A, Hemmati M, et al. Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. BioMed Central Ltd; 2021;16:1–13. Salari N, Darvishi N, Bartina Y, Larti M, Kiaei A, Hemmati M, et al. Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. BioMed Central Ltd; 2021;16:1–13.
19.
Zurück zum Zitat Li Y, Hao W, Guan J, Li B, Meng L, Sun S, et al. Relationship between indices of circulating blood cells and bone homeostasis in osteoporosis. Front Endocrinol (Lausanne). Frontiers Media S.A.; 2022;13:2163. Li Y, Hao W, Guan J, Li B, Meng L, Sun S, et al. Relationship between indices of circulating blood cells and bone homeostasis in osteoporosis. Front Endocrinol (Lausanne). Frontiers Media S.A.; 2022;13:2163.
20.
Zurück zum Zitat Dé Rique Turcotte Id A-F, O’connor S, Morin SN, Gibbs JC, Willie BM, Jean S, et al. Association between obesity and risk of fracture, bone mineral density and bone quality in adults: a systematic review and meta-analysis. PLoS One. 2021;16(6):e0252487. Dé Rique Turcotte Id A-F, O’connor S, Morin SN, Gibbs JC, Willie BM, Jean S, et al. Association between obesity and risk of fracture, bone mineral density and bone quality in adults: a systematic review and meta-analysis. PLoS One. 2021;16(6):e0252487.
21.
Zurück zum Zitat Vadera S, Osborne T, Shah V, Stephenson JA. Opportunistic screening for osteoporosis by abdominal CT in a British population. Insights into imaging 2023 141. SpringerOpen; 2023;14:1–8. Vadera S, Osborne T, Shah V, Stephenson JA. Opportunistic screening for osteoporosis by abdominal CT in a British population. Insights into imaging 2023 141. SpringerOpen; 2023;14:1–8.
22.
Zurück zum Zitat Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, et al. PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging. Springer Berlin Heidelberg; 2023;1466–86. Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, et al. PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging. Springer Berlin Heidelberg; 2023;1466–86.
23.
Zurück zum Zitat Li H, Zhang X, Zhang Q, Zhang Q, Zhu X, Xie T, et al. The relationship between the monocyte-to-lymphocyte ratio and osteoporosis in postmenopausal females with T2DM: a retrospective study in Chinese population. Front Endocrinol (Lausanne). 2023;14:1–7. Li H, Zhang X, Zhang Q, Zhang Q, Zhu X, Xie T, et al. The relationship between the monocyte-to-lymphocyte ratio and osteoporosis in postmenopausal females with T2DM: a retrospective study in Chinese population. Front Endocrinol (Lausanne). 2023;14:1–7.
24.
Zurück zum Zitat Gao K, Zhu W, Liu W, Ma D, Li H, Yu W, et al. The predictive role of monocyte-to-lymphocyte ratio in osteoporosis patient. Med (United States). Lippincott Williams and Wilkins; 2019;98. Gao K, Zhu W, Liu W, Ma D, Li H, Yu W, et al. The predictive role of monocyte-to-lymphocyte ratio in osteoporosis patient. Med (United States). Lippincott Williams and Wilkins; 2019;98.
25.
Zurück zum Zitat Lee JH, Kim JH, Hong AR, Kim SW, Shin CS. Optimal body mass index for minimizing the risk for osteoporosis and type 2 diabetes. Korean J Intern Med. 2020;35:1432–42.CrossRefPubMed Lee JH, Kim JH, Hong AR, Kim SW, Shin CS. Optimal body mass index for minimizing the risk for osteoporosis and type 2 diabetes. Korean J Intern Med. 2020;35:1432–42.CrossRefPubMed
26.
Zurück zum Zitat Pickhardt PJ, Pooler BD, Lauder T, del Rio AM, Bruce RJ, Binkley N. Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med. 2013;158:588–95.CrossRefPubMedPubMedCentral Pickhardt PJ, Pooler BD, Lauder T, del Rio AM, Bruce RJ, Binkley N. Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med. 2013;158:588–95.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Jang S, Graffy PM, Ziemlewicz TJ, Lee SJ, Summers RM, Pickhardt PJ. Opportunistic osteoporosis screening at routine abdominal and thoracic CT: normative L1 trabecular attenuation values in more than 20 000 adults. Radiology. Radiological Society of North America Inc.; 2019;291:360–7. Jang S, Graffy PM, Ziemlewicz TJ, Lee SJ, Summers RM, Pickhardt PJ. Opportunistic osteoporosis screening at routine abdominal and thoracic CT: normative L1 trabecular attenuation values in more than 20 000 adults. Radiology. Radiological Society of North America Inc.; 2019;291:360–7.
28.
Zurück zum Zitat Palumbo C, Dalla Volta A, Zamboni S, Mazziotti G, Zamparini M, Triggiani L, et al. Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study. J Clin Endocrinol Metab. 2022;107(12):3398–3407. Palumbo C, Dalla Volta A, Zamboni S, Mazziotti G, Zamparini M, Triggiani L, et al. Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study. J Clin Endocrinol Metab. 2022;107(12):3398–3407.
29.
Zurück zum Zitat Dalla Volta A, Palumbo C, Zamboni S, Mazziotti G, Triggiani L, Zamparini M, et al. Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study. J Clin Endocrinol Invest. 2023. https://doi.org/10.1007/s40618-023-02150-z.CrossRef Dalla Volta A, Palumbo C, Zamboni S, Mazziotti G, Triggiani L, Zamparini M, et al. Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study. J Clin Endocrinol Invest. 2023. https://​doi.​org/​10.​1007/​s40618-023-02150-z.CrossRef
30.
31.
Zurück zum Zitat Tuckermann J, Adams RH. Crosstalk between endothelial cells and bone in development, homeostasis and inflammatory disease. Nat Rev Rheumatol. Europe PMC Funders; 2021;17:608. Tuckermann J, Adams RH. Crosstalk between endothelial cells and bone in development, homeostasis and inflammatory disease. Nat Rev Rheumatol. Europe PMC Funders; 2021;17:608.
32.
Zurück zum Zitat Ganguly P, El-Jawhari JJ, Giannoudis PV, Burska AN, Ponchel F, Jones EA. Age-related changes in bone marrow mesenchymal stromal cells: a potential impact on osteoporosis and osteoarthritis development. Cell Transplant. 2017;26:1520–9.CrossRefPubMedPubMedCentral Ganguly P, El-Jawhari JJ, Giannoudis PV, Burska AN, Ponchel F, Jones EA. Age-related changes in bone marrow mesenchymal stromal cells: a potential impact on osteoporosis and osteoarthritis development. Cell Transplant. 2017;26:1520–9.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Morimoto R, Uehara S, Yatsushiro S, Juge N, Hua Z, Senoh S, et al. Secretion of L-glutamate from osteoclasts through transcytosis. EMBO J. 2006;25:4175–86.CrossRefPubMedPubMedCentral Morimoto R, Uehara S, Yatsushiro S, Juge N, Hua Z, Senoh S, et al. Secretion of L-glutamate from osteoclasts through transcytosis. EMBO J. 2006;25:4175–86.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Riggs BL, Khosla S, Melton LJ. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 2002;23:279–302.CrossRefPubMed Riggs BL, Khosla S, Melton LJ. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 2002;23:279–302.CrossRefPubMed
35.
Zurück zum Zitat Barrett-Connor E, Nielson CM, Orwoll E, Bauer DC, Cauley JA. Epidemiology of rib fractures in older men: Osteoporotic Fractures in Men (MrOS) prospective cohort study. BMJ. BMJ Publishing Group; 2010;340:798. Barrett-Connor E, Nielson CM, Orwoll E, Bauer DC, Cauley JA. Epidemiology of rib fractures in older men: Osteoporotic Fractures in Men (MrOS) prospective cohort study. BMJ. BMJ Publishing Group; 2010;340:798.
36.
Zurück zum Zitat Prins JTH, Van Lieshout EMM, Reijnders MRL, Verhofstad MHJ, Wijffels MME. Rib fractures after blunt thoracic trauma in patients with normal versus diminished bone mineral density: a retrospective cohort study. Osteoporos Int. 2020;31(2):225–231. Prins JTH, Van Lieshout EMM, Reijnders MRL, Verhofstad MHJ, Wijffels MME. Rib fractures after blunt thoracic trauma in patients with normal versus diminished bone mineral density: a retrospective cohort study. Osteoporos Int. 2020;31(2):225–231.
37.
Zurück zum Zitat Krappinger D, Kammerlander C, Hak DJ, Blauth M. Low-energy osteoporotic pelvic fractures. Arch Orthop Trauma Surg. 2010;130(9):1167–75. Krappinger D, Kammerlander C, Hak DJ, Blauth M. Low-energy osteoporotic pelvic fractures. Arch Orthop Trauma Surg. 2010;130(9):1167–75.
38.
Zurück zum Zitat Kannus P, Palvanen M, Niemi S, Parkkari J, Järvinen M. Epidemiology of osteoporotic pelvic fractures in elderly people in Finland: sharp increase in 1970–1997 and alarming projections for the new millennium. Osteo Int. 2000;11(5):443.8. Kannus P, Palvanen M, Niemi S, Parkkari J, Järvinen M. Epidemiology of osteoporotic pelvic fractures in elderly people in Finland: sharp increase in 1970–1997 and alarming projections for the new millennium. Osteo Int. 2000;11(5):443.8.
39.
Zurück zum Zitat Kuo TR, Chen CH. Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. Biomark Res. 2017;5:18. Kuo TR, Chen CH. Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. Biomark Res. 2017;5:18.
40.
Zurück zum Zitat Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, et al. Osteoporosis in men: an endocrine society clinical practice guideline. J Clin Endocrinol Metab Oxford Academic. 2012;97:1802–22.CrossRef Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, et al. Osteoporosis in men: an endocrine society clinical practice guideline. J Clin Endocrinol Metab Oxford Academic. 2012;97:1802–22.CrossRef
41.
Zurück zum Zitat Vollnberg B, Alberts I, Genitsch V, Rominger A, Afshar-Oromieh A. Assessment of malignancy and PSMA expression of uncertain bone foci in [18F]PSMA-1007 PET/CT for prostate cancer-a single-centre experience of PET-guided biopsies. Eur J Nucl Med Mol Imaging. 2022;49:3910–6. Vollnberg B, Alberts I, Genitsch V, Rominger A, Afshar-Oromieh A. Assessment of malignancy and PSMA expression of uncertain bone foci in [18F]PSMA-1007 PET/CT for prostate cancer-a single-centre experience of PET-guided biopsies. Eur J Nucl Med Mol Imaging. 2022;49:3910–6.
42.
Zurück zum Zitat Chen MY, Franklin A, Yaxley J, Gianduzzo T, McBean R, Wong D, et al. Solitary rib lesions showing prostate-specific membrane antigen (PSMA) uptake in pre-treatment staging 68 Ga-PSMA-11 positron emission tomography scans for men with prostate cancer: benign or malignant? BJU Int. 2020;126:396–401.CrossRefPubMed Chen MY, Franklin A, Yaxley J, Gianduzzo T, McBean R, Wong D, et al. Solitary rib lesions showing prostate-specific membrane antigen (PSMA) uptake in pre-treatment staging 68 Ga-PSMA-11 positron emission tomography scans for men with prostate cancer: benign or malignant? BJU Int. 2020;126:396–401.CrossRefPubMed
Metadaten
Titel
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake
verfasst von
Gaia Ninatti
Cristiano Pini
Fabrizia Gelardi
Samuele Ghezzo
Paola Mapelli
Maria Picchio
Lidija Antunovic
Alberto Briganti
Francesco Montorsi
Claudio Landoni
Martina Sollini
Arturo Chiti
Publikationsdatum
12.09.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 1/2023
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-023-06424-9